28.72 USD
+0.87 (+3.12%)
At close: Feb 6, 2026
28.72 USD
0 (0%)
After Hours: 2/6/2026, 8:18:51 PM
Taking everything into account, AZTA scores 4 out of 10 in our fundamental rating. AZTA was compared to 58 industry peers in the Life Sciences Tools & Services industry. No worries on liquidiy or solvency for AZTA as it has an excellent financial health rating, but there are worries on the profitability. AZTA is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year AZTA was profitable.
- AZTA had a positive operating cash flow in the past year.
- In multiple years AZTA reported negative net income over the last 5 years.
- AZTA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- AZTA has a Return On Assets (-2.71%) which is in line with its industry peers.
- AZTA's Return On Equity of -3.23% is in line compared to the rest of the industry. AZTA outperforms 57.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.71% | ||
| ROE | -3.23% | ||
| ROIC | N/A |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- AZTA has a Gross Margin (45.52%) which is in line with its industry peers.
- AZTA's Gross Margin has been stable in the last couple of years.
- AZTA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.52% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
- AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- AZTA has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, AZTA has less shares outstanding
- Compared to 1 year ago, AZTA has an improved debt to assets ratio.
2.2 Solvency
- AZTA has an Altman-Z score of 3.87. This indicates that AZTA is financially healthy and has little risk of bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 3.87, AZTA is in the better half of the industry, outperforming 75.44% of the companies in the same industry.
- AZTA has a debt to FCF ratio of 0.04. This is a very positive value and a sign of high solvency as it would only need 0.04 years to pay back of all of its debts.
- AZTA has a better Debt to FCF ratio (0.04) than 92.98% of its industry peers.
- AZTA has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
- The Debt to Equity ratio of AZTA (0.00) is better than 75.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.04 | ||
| Altman-Z | 3.87 |
ROIC/WACCN/A
WACC10.95%
2.3 Liquidity
- A Current Ratio of 2.98 indicates that AZTA has no problem at all paying its short term obligations.
- AZTA has a Current ratio of 2.98. This is comparable to the rest of the industry: AZTA outperforms 54.39% of its industry peers.
- A Quick Ratio of 2.66 indicates that AZTA has no problem at all paying its short term obligations.
- AZTA's Quick ratio of 2.66 is in line compared to the rest of the industry. AZTA outperforms 56.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.98 | ||
| Quick Ratio | 2.66 |
3. Growth
3.1 Past
- AZTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.89%, which is quite good.
- The earnings per share for AZTA have been decreasing by -16.04% on average. This is quite bad
- The Revenue has been growing slightly by 3.55% in the past year.
- The Revenue has been growing by 8.86% on average over the past years. This is quite good.
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
Revenue 1Y (TTM)3.55%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
3.2 Future
- Based on estimates for the next years, AZTA will show a very strong growth in Earnings Per Share. The EPS will grow by 27.49% on average per year.
- AZTA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.37% yearly.
EPS Next Y51.12%
EPS Next 2Y39.62%
EPS Next 3Y33.99%
EPS Next 5Y27.49%
Revenue Next Year4.59%
Revenue Next 2Y4.91%
Revenue Next 3Y5.2%
Revenue Next 5Y5.37%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- AZTA is valuated quite expensively with a Price/Earnings ratio of 53.19.
- AZTA's Price/Earnings ratio is in line with the industry average.
- Compared to an average S&P500 Price/Earnings ratio of 27.93, AZTA is valued quite expensively.
- A Price/Forward Earnings ratio of 27.80 indicates a quite expensive valuation of AZTA.
- Based on the Price/Forward Earnings ratio, AZTA is valued a bit cheaper than the industry average as 70.18% of the companies are valued more expensively.
- AZTA's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.77.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.19 | ||
| Fwd PE | 27.8 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, AZTA is valued a bit cheaper than the industry average as 64.91% of the companies are valued more expensively.
- AZTA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AZTA is cheaper than 68.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.37 | ||
| EV/EBITDA | 23.18 |
4.3 Compensation for Growth
- AZTA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- A more expensive valuation may be justified as AZTA's earnings are expected to grow with 33.99% in the coming years.
PEG (NY)1.04
PEG (5Y)N/A
EPS Next 2Y39.62%
EPS Next 3Y33.99%
5. Dividend
5.1 Amount
- AZTA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
28.72
+0.87 (+3.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)05-05 2026-05-05/amc
Inst Owners111.91%
Inst Owner ChangeN/A
Ins Owners0.63%
Ins Owner Change12.39%
Market Cap1.32B
Revenue(TTM)593.82M
Net Income(TTM)-55.76M
Analysts75.71
Price Target40.22 (40.04%)
Short Float %9.08%
Short Ratio5.66
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.43%
Min EPS beat(2)8.65%
Max EPS beat(2)36.22%
EPS beat(4)3
Avg EPS beat(4)13.04%
Min EPS beat(4)-29.97%
Max EPS beat(4)37.26%
EPS beat(8)7
Avg EPS beat(8)70.99%
EPS beat(12)10
Avg EPS beat(12)146.49%
EPS beat(16)14
Avg EPS beat(16)123.62%
Revenue beat(2)0
Avg Revenue beat(2)-2.8%
Min Revenue beat(2)-5.56%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.05%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)4
Avg Revenue beat(12)-1.11%
Revenue beat(16)7
Avg Revenue beat(16)-0.95%
PT rev (1m)1.47%
PT rev (3m)22.67%
EPS NQ rev (1m)1.29%
EPS NQ rev (3m)-19.13%
EPS NY rev (1m)0.27%
EPS NY rev (3m)1.47%
Revenue NQ rev (1m)-0.27%
Revenue NQ rev (3m)-3.58%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.19 | ||
| Fwd PE | 27.8 | ||
| P/S | 2.22 | ||
| P/FCF | 34.37 | ||
| P/OCF | 18.25 | ||
| P/B | 0.76 | ||
| P/tB | 1.43 | ||
| EV/EBITDA | 23.18 |
EPS(TTM)0.54
EY1.88%
EPS(NY)1.03
Fwd EY3.6%
FCF(TTM)0.84
FCFY2.91%
OCF(TTM)1.57
OCFY5.48%
SpS12.95
BVpS37.66
TBVpS20.12
PEG (NY)1.04
PEG (5Y)N/A
Graham Number21.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.71% | ||
| ROE | -3.23% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.52% | ||
| FCFM | 6.45% |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.04 | ||
| Debt/EBITDA | 0.02 | ||
| Cap/Depr | 55.31% | ||
| Cap/Sales | 5.7% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 182.57% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.98 | ||
| Quick Ratio | 2.66 | ||
| Altman-Z | 3.87 |
F-Score5
WACC10.95%
ROIC/WACCN/A
Cap/Depr(3y)47.53%
Cap/Depr(5y)73.52%
Cap/Sales(3y)6.46%
Cap/Sales(5y)8.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
EPS Next Y51.12%
EPS Next 2Y39.62%
EPS Next 3Y33.99%
EPS Next 5Y27.49%
Revenue 1Y (TTM)3.55%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
Revenue Next Year4.59%
Revenue Next 2Y4.91%
Revenue Next 3Y5.2%
Revenue Next 5Y5.37%
EBIT growth 1Y70.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year516.37%
EBIT Next 3Y105.69%
EBIT Next 5YN/A
FCF growth 1Y210.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.11%
OCF growth 3YN/A
OCF growth 5Y13.75%
AZENTA INC / AZTA FAQ
Can you provide the ChartMill fundamental rating for AZENTA INC?
ChartMill assigns a fundamental rating of 4 / 10 to AZTA.
What is the valuation status of AZENTA INC (AZTA) stock?
ChartMill assigns a valuation rating of 4 / 10 to AZENTA INC (AZTA). This can be considered as Fairly Valued.
How profitable is AZENTA INC (AZTA) stock?
AZENTA INC (AZTA) has a profitability rating of 2 / 10.
Can you provide the financial health for AZTA stock?
The financial health rating of AZENTA INC (AZTA) is 7 / 10.
How sustainable is the dividend of AZENTA INC (AZTA) stock?
The dividend rating of AZENTA INC (AZTA) is 0 / 10 and the dividend payout ratio is 0%.